="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sale reported on this Form 144 reflects an amount necessary to cover the tax liability incurred in connection with the vesting of restricted stock units.

Date of Notice

06/17/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Andrea Machelle Sanders

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

BCRX BioCryst Pharmaceuticals Inc

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Noticias sobre BioCryst Pharmaceuticals Inc BCRX

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

BCRX BioCryst Pharmaceuticals Inc

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Noticias sobre BioCryst Pharmaceuticals Inc BCRX

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación